Diagnostica Stago, Inc. recalls STA Satellite. Product Code: All references. All software versions. The STA Satellite is a fully automated benchtop ana…
- Recall date
- July 21, 2025
- Source
- U.S. Food & Drug Administration (FDA) — enforcement report
- Recall number
- Z-2473-2025
- FDA classification
- Class II
- Brand / firm
- Diagnostica Stago, Inc.
- Sold / distributed
- Worldwide - US Nationwide distribution in the states of AL, AZ, CA, CO, FL, GA, LA, MD, ME, MN, MO, MT, NC, OH, OK, OR, PA, PR, SD, VT, WI, WY and the countries of Algeria, Argentina, Austria, Brazil, Bulgaria, Canada, Chile, Colombia, Costa Rica, France, French Polynesie, Guadeloupe, India, Iran,…
Why it was recalled
Potential for contamination of STA-LIQUID ANTI-Xa by Stago Fibrinogen reagents in UFH and LMWH applications.
Class II means using this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.
What was recalled
STA Satellite. Product Code: All references. All software versions. The STA Satellite is a fully automated benchtop analyzer capable of simultaneously performing clotting, chromogenic, and immunologic assays.
Get recall alerts
Free email alert whenever Diagnostica Stago, Inc. has a new recall — straight from official government data. Unsubscribe anytime.
More recalls from: Diagnostica Stago, Inc.